Insulin Detemir Dosage
Links shared publicly online about this topic
No increased cancer risk with insulin detemir vs. human insulin
endocrinetoday.com — “45th Annual Meeting of the European Association for the Study of Diabetes Long-acting insulin detemir was not associated with any increase in t” View full resource at endocrinetoday.com
Most Recently Shared on October 5, 2009 at 6:32 pm By:
#EASD09: No increased #cancer risk with #insulin detemir vs. human insulin http://ow.ly/sNsz
Detemir as a once-daily basal insulin in type 2 diabetes
dovepress.com — “Peer reviewed article authored by (Nelson SE). Read article or submit your manuscript for publishing.” View full resource at dovepress.com
Most Recently Shared on August 26, 2011 at 11:14 am By:
Detemir as a once-daily basal insulin in type 2 diabetes: Nelson SE (Source: International Journal of COPD) http://t.co/5bokRIW
Insulin detemir versus insulin glargine for type 2 diabetes mellitus
instapaper.com — “Insulin detemir versus insulin glargine for type 2 diabetes mellitus” View full resource at instapaper.com
Most Recently Shared on July 12, 2011 at 1:53 pm By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
No clinically relevant difference in the efficacy or the safety between the use of insulin detemir and insulin glargine. http://t.co/cmCKWb0
Insulin detemir versus insulin glargine for type 2... [Cochrane Database Syst Rev. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on July 15, 2011 at 6:12 am By:
Insulin detemir versus insulin glargine for type 2 diabetes mellitus.: Authors: Swinnen SG, Simon AC, Holleman F... http://bit.ly/oQPhXa
Study Finds Visually Impaired People Get Insulin Pen Dosages Right
medicalnewstoday.com — “Labels on the popular insulin pen used by people with diabetes warn against visually-impaired people using pens to measure out and administer their insulin dosage.A Case Western Reserve” View full resource at medicalnewstoday.com
Most Recently Shared on July 3, 2010 at 12:04 pm By:
Study Finds Visually Impaired People Get Insulin Pen Dosages Right http://mnt.to/3FH8 #eyehealth
Endocrinology Article | Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes
mdlinx.com — “Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes” View full resource at mdlinx.com
Most Recently Shared on October 7, 2011 at 11:36 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type... http://t.co/G22vgjLc #endo
Insulin Detemir Reduces Weight Gain As a Result of Reduced Food Intake in Patients With Type 1 Diabetes
care.diabetesjournals.org — “Insulin Detemir Reduces Weight Gain As a Result of Reduced Food Intake in Patients With Type 1 Diabetes” View full resource at care.diabetesjournals.org
Most Recently Shared on May 26, 2011 at 6:34 am By:
Insulin Detemir Reduces Weight Gain As Result of Reduced Food Intake in Patients With Type 1 Diabetes (Diabetes Care) http://bit.ly/j7eqTr?
Mixing Insulin Aspart With Detemir Does Not Affect Glucose Excursion In Children With Type 1 Diabetes Mellitus " Diabetes Care
care.diabetesjournals.org — “Mixing Insulin Aspart With Detemir Does Not Affect Glucose Excursion In Children With Type 1 Diabetes Mellitus " Diabetes Care” View full resource at care.diabetesjournals.org
Most Recently Shared on June 4, 2010 at 8:46 pm By:
Mixing #Insulin Aspart With Detemir Does Not Affect Glucose Excursion In Children With Type 1 #Diabetes Mellitus http://bit.ly/bkC3Wn
NYTimes: Insulin Study Could Lead to New Dosage Devices - Personal Medicine
personalmedicine.posterous.com — “NYTimes: Insulin Study Could Lead to New Dosage Devices - Personal Medicine” View full resource at personalmedicine.posterous.com
Most Recently Shared on February 5, 2010 at 3:16 am By:
Personal Medicine in Paducah, Kentucky. Dr Hodge was a featured speaker at the Mayo Clinic's Transform Symposium
in '09 and has been named by Brian Dolan of Mobi Heath News as "The
First iPhone Doctor". She is the author of The Personal Pediatrics Primer for the Progressive Parent.
Dr. Hodge's special interests in pediatrics include nutrition,
prevention and the potential for the internet to strengthen physician
patient relationships. Dr. Hodge is a member of the Health care
Information and Management Systems Society (HIMSS), a Fellow of the
Academy of Pediatrics' Quality and Innovation Network, and a founding
member of the Society for Participatory Medicine. Participatory Medicine
is an emerging group of engaged patients and physicians who believe
that mutual trust and understanding as well as use of media, health IT strengthens the physician patient relationship and provides for better care." /> Natalie Hodge, MD, FAAP Pediatrician, Physician, Active Health Library, and Doctor
NYTimes: Insulin Study Could Lead to New Dosage Devices http://post.ly/MFbV
Insulin Study Could Lead to New Dosage Devices - NYTimes.com
nytimes.com — “A new study points toward a different way of regulating children’s glucose levels by using a continuous glucose monitor instead of the standard diabetes management system.” View full resource at nytimes.com
Most Recently Shared on February 5, 2010 at 7:23 am By:
Insulin Study Could Lead to New Dosage Devices (via @nytimes): http://nyti.ms/awf1Dc
Insulin Study Could Lead to New Dosage Devices - NYTimes.com
nytimes.com — “A new study points toward a different way of regulating children’s glucose levels by using a continuous glucose monitor instead of the standard diabetes management system.” View full resource at nytimes.com
Most Recently Shared on February 5, 2010 at 2:48 am By:
Insulin Study Could Lead to New Dosage Devices http://nyti.ms/9O77cP
An increased dose of insulin detemir improves glycaemic control and reduces body weight of Japanese patients with ... http://bit.ly/aOu82L
www3.interscience.wiley.com — “An increased dose of insulin detemir improves glycaemic control and reduces body weight of Japanese patients with ... http://bit.ly/aOu82L” View full resource at www3.interscience.wiley.com
Most Recently Shared on July 30, 2010 at 11:40 am By:
An increased dose of insulin detemir improves glycaemic control and reduces body weight of Japanese patients with ... http://bit.ly/aOu82L
Insulin Study Could Lead to New Dosage Devices - NYTimes.com
nytimes.com — “A new study points toward a different way of regulating children’s glucose levels by using a continuous glucose monitor instead of the standard diabetes management system.” View full resource at nytimes.com
Most Recently Shared on February 7, 2010 at 5:29 pm By:
Helen Hilts, MD Active Health Library, Doctor, Family Medicine Doctor, and Physician
NY Times's take on developing an 'artificial pancreas' http://nyti.ms/9PSWvO. Maybe someday soon!
Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial - Hollander - 2011 - Diabetes, Obesity and Metabolism - Wiley Online Library
onlinelibrary.wiley.com — “Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial - Hollander - 2011 - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on January 25, 2011 at 12:05 am By:
Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION ... http://bit.ly/i8R0Qc
Efficacy and safety of insulin detemir once-daily in combination with sitagliptin and metformin: the Transition™ randomised controlled trial - Hollander - Diabetes, Obesity and Metabolism - Wiley Online Library
onlinelibrary.wiley.com — “Efficacy and safety of insulin detemir once-daily in combination with sitagliptin and metformin: the Transition™ randomised controlled trial - Hollander - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on December 4, 2010 at 9:17 am By:
Efficacy and safety of insulin detemir onceâ€*daily in combination with sitagliptin and metformin: the Transitio... http://bit.ly/eIe5dP
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Endocrine Today
The official Twitter for Endocrine Today, clinical news on diabetes and endocrine disorders.
-
Diabetes, Type 2
Organizing type 2 diabetes resources shared by health experts, advocates, and organizations into WisdomCards.
-
Yvo Sijpkens MD
Internist-Nephrologist, Expert in Hypertension and Chronic Kidney Disease, Focus on Cardiovascular and Renal Protection by Lifestyle, Vit D and Pharmacotherapy
Advertisement
